Cetera Advisors LLC Amgen Inc Transaction History

Cetera Advisors LLC

$0
Q1 2024

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $11.5 Million - $13.9 Million	42,739 Added 151.32%	70,984 $20.2 Million
Q4 2023 Feb 13, 2024	BUY	$255.7 - $288.46 $1.22 Million - $1.38 Million	4,768 Added 20.31%	28,245 $8.14 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $485,621 - $602,912	2,221 Added 10.45%	23,477 $6.31 Million
Q2 2023 Aug 09, 2023	SELL	$214.27 - $253.37 $351,617 - $415,780	-1,641 Reduced 7.17%	21,256 $4.72 Million
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $79,026 - $96,320	-350 Reduced 1.51%	22,897 $5.54 Million
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $3.61 Million - $4.58 Million	-15,753 Reduced 40.39%	23,247 $6.11 Million
Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $4.91 Million - $5.54 Million	21,882 Added 127.83%	39,000 $9,000
Q2 2022 Aug 11, 2022	SELL	$230.71 - $256.74 $85,362 - $94,993	-370 Reduced 2.12%	17,118 $4.17 Million
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $51,089 - $56,518	233 Added 1.35%	17,488 $4.23 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $571,780 - $654,350	-2,875 Reduced 14.28%	17,255 $3.88 Million
Q3 2021 Nov 16, 2021	BUY	$212.27 - $248.7 $701,127 - $821,456	3,303 Added 19.63%	20,130 $4.28 Million
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $21,722 - $24,100	93 Added 0.56%	16,827 $4.1 Million
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $626,895 - $730,545	2,825 Added 20.31%	16,734 $4.16 Million
Q4 2020 Feb 17, 2021	BUY	$216.38 - $257.67 $672,725 - $801,096	3,109 Added 28.79%	13,909 $3.2 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $581,932 - $647,156	2,480 Added 29.81%	10,800 $2.75 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $139,258 - $170,888	-704 Reduced 7.8%	8,320 $1.96 Million
Q1 2020 May 08, 2020	BUY	$182.24 - $241.7 $250,033 - $331,612	1,372 Added 17.93%	9,024 $1.83 Million
Q4 2019 Feb 10, 2020	BUY	$189.21 - $243.2 $567 - $729	3 Added 0.04%	7,652 $1.84 Million
Q3 2019 Nov 06, 2019	SELL	$174.11 - $208.62 $610,951 - $732,047	-3,509 Reduced 31.45%	7,649 $1.48 Million
Q2 2019 Aug 12, 2019	SELL	$166.7 - $195.41 $63,846 - $74,842	-383 Reduced 3.32%	11,158 $2.06 Million
Q1 2019 May 06, 2019	SELL	$180.87 - $203.88 $94,595 - $106,629	-523 Reduced 4.34%	11,541 $2.19 Million
Q4 2018 Feb 15, 2019	BUY	$178.4 - $208.25 $90,092 - $105,166	505 Added 4.37%	12,064 $2.34 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $374,285 - $421,957	2,020 Added 21.18%	11,559 $2.39 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $49,648 - $55,766	-299 Reduced 3.04%	9,539 $1.76 Million
Q1 2018 May 09, 2018	SELL	$169.43 - $198.0 $404,429 - $472,626	-2,387 Reduced 19.53%	9,838 $1.68 Million
Q4 2017 Feb 08, 2018	BUY	$168.79 - $188.59 $106,844 - $119,377	633 Added 5.46%	12,225 $2.13 Million
Q3 2017 Nov 16, 2017	SELL	$167.29 - $191.0 $41,989 - $47,941	-251 Reduced 2.12%	11,592 $2.16 Million
Q2 2017 Aug 14, 2017	BUY	N/A	11,843	11,843 $2.04 Million

Others Institutions Holding AMGN

# of Institutions

3,084

Shares Held

401M

Call Options Held

7.56M

Put Options Held

7.16M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $153B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisors LLC with notifications on news.

Account